Alex Sapir Fulcrum Therapeutics, Inc. (FULC) insider trading activity

FULC Quotes by TradingView

Alex Sapir is of Fulcrum Therapeutics, Inc.. Currently has a direct ownership of 193,360 shares of FULC, which is worth approximately $854,651. The most recent transaction as insider was on Jul 03, 2024, when has been sold 150,000 shares (Common Stock) at a price of $3.27 per share, resulting in proceeds of $490,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 193K
0% 3M change
n/a 12M change
Total Value Held $854,651

Alex Sapir Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 03 2024
BUY
Exercise of conversion of derivative security
$490,500 $3.27 p/Share
150,000 Added 43.69%
193,360 Common Stock
Mar 04 2024
BUY
Open market or private purchase
$492,136 $11.35 p/Share
43,360 Added 50.0%
43,360 Common Stock

Also insider at

PHAS
PhaseBio Pharmaceuticals Inc Healthcare
Director
AS

Alex Sapir

Malvern, PA

Track Institutional and Insider Activities on FULC

Follow Fulcrum Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FULC shares.

Notify only if

Insider Trading

Get notified when an Fulcrum Therapeutics, Inc. insider buys or sells FULC shares.

Notify only if

News

Receive news related to Fulcrum Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FULC